Why ClearPath Is Single-Use Only (Sterility, Safety, and Performance)

A common and reasonable question before a nasal procedure is: “If it’s used briefly, can’t it be cleaned and reused?” For the ClearPath Nasal Balloon Catheter (CNB) device, the answer is no—ClearPath single-use-only labeling is intentional and important. If you’re considering treatment with the ClearPath Nasal Balloon Catheter (CNB), you can learn more about the device on the ClearPath Nasal Balloon Catheter (CNB) product page.

This article explains what “single-use” means in plain language, why it matters for safety and performance, and what you can expect from your ENT clinic before and during treatment. ClearPath may be an option for some patients instead of more traditional septoplasty approaches, depending on anatomy and a clinician’s assessment.

What “Single-Use Only” Means (In Plain Language)

Single-use = one patient, one procedure

“Single-use only” means a sterile, single-patient-use medical device is opened and used one time for one patient—then disposed of according to medical waste disposal protocols.

This is not about convenience. For a device that goes into sensitive nasal tissues, single-use helps achieve two practical goals:

- protecting patients from avoidable infection risks

- supporting performance consistency

A simple way to think about it: the device is manufactured, packaged, and tested assuming one controlled life cycle—open → use → discard.

Why labeling matters

Medical devices are tested, validated, and cleared for specific intended uses. That includes whether a device is designed to be single-use or reusable. With ClearPath single-use-only labeling, safety and performance testing are built around one controlled cycle of use—not multiple cycles of use, cleaning, and re-sterilization. For official handling guidance, see the manufacturer’s Instructions for Use (IFU).

In short: single-use means one patient, one procedure, then proper disposal.

Single-use life cycle: open → use → discard

The #1 Reason: Sterility and Infection Prevention

Reuse can introduce germs—even after cleaning

The nose is not a sterile environment, and any procedure in the nasal passage must take infection prevention seriously. Even careful cleaning can miss microscopic interfaces, tiny crevices, or areas that are hard to access. If even a very small amount of contamination remains, it can still matter—because it’s being introduced into sensitive tissue where the body is trying to heal.

A quick analogy: “kitchen-clean” vs. “procedure-clean”

- A cutting board can look clean and still harbor bacteria in tiny grooves.

- A medical device can look clean and still have microscopic residue in areas you can’t see or easily reach.

Single-use design helps avoid the risks that can come with trying to re-clean and re-sterilize something that wasn’t designed to be reprocessed.

Single-use helps reduce cross-contamination risk between patients

Single-use supports a clear safety goal: one-patient sterility assurance. When a new ClearPath Nasal Balloon Catheter (CNB) device is opened for your procedure, it lowers the chance that germs could be transferred from one person to another through device reuse. In many settings, opening a sterile device just before use and disposing of it afterward helps support infection prevention.

Single-use is common when sterility assurance is critical

Many procedural tools are labeled for single-use when consistent sterility assurance is a key safety requirement. If you want a safety-focused overview of this topic, see how ClearPath reduces risks in septoplasty.

Bottom line: starting with a sterile, unused device helps support infection prevention in nasal procedures.

Sterility barrier prevents cross-contamination

Device Performance: ClearPath Is Designed to Work Once, Reliably

Performance consistency matters

Beyond sterility, patients and clinicians value performance that behaves as expected under the conditions the device was tested for.

Materials and mechanics can change after one use

A single-use nasal balloon catheter relies on specific balloon expansion behavior—how it inflates, holds shape, and deflates. After one full inflation/deflation cycle, the material’s behavior can change. A balloon that has already expanded once may not expand exactly the same way the second time. Even small differences in stiffness, responsiveness, or shape retention can matter when controlled, repeatable performance is the goal.

Clinician perspective (what “consistent” looks like)

Clinicians aim for the device to behave the same way every time because consistency can support safety. Aligning real-world use with how the device was designed and evaluated helps maintain that consistency.

One-time balloon performance consistency

Packaging is part of the safety system

Sterile packaging protects the device from contamination until the moment it’s needed. Once the package is opened, sterility cannot be guaranteed in the same way. This is another practical reason ClearPath single-use-only labeling exists: it helps protect the chain of sterility from manufacturing to procedure.

Using the device once, as intended, supports the consistent performance it was designed for.

Packaging is part of the safety system

What the Clinical Evidence Says About Safety (And Why Single-Use Supports It)

Clinical reporting is one piece of the bigger picture. A retrospective review by Dillard and colleagues described outcomes using a force-directed balloon-assisted endoscopic septoplasty technique with the ClearPath Nasal Balloon Catheter (CNB) device.

Reported outcomes in a large cohort (as described by the authors)

- 107 consecutive cases

- 23 patients with both pre- and post-procedure CT scans

- 43 patients who completed SNOT-22 symptom surveys

(Dillard et al., 2026)

In this retrospective cohort, no major complications were reported

As reported by the authors, major complications were not observed, including:

- no septal perforation

- no hematoma

- no mucosal injury

- no infection

- no synechiae

- no conversion to traditional septoplasty

(Dillard et al., 2026)

Individual risks still vary, and complications can occur.

Symptom improvement was reported after the procedure

Among patients who completed SNOT-22 surveys, scores improved from 58.7 to 44.8 at one month (a 23.8% reduction). The largest improvements were reported in:

- congestion

- headache/facial pressure

- sleep quality

(Dillard et al., 2026)

CT imaging showed septal alignment improvement in the subgroup with scans

Mean symmetry improved by:

- 22% at the nasolacrimal duct (NLD)

- 45% at the point of maximal deviation (PMD)

(Dillard et al., 2026)

Evidence to date is encouraging, but decisions should be individualized with your clinician.

Why Clinics Typically Can’t “Just Reprocess It”

Reprocessing is complex—and not the same as cleaning

- Cleaning removes visible debris.

- Disinfection/sterilization aims to eliminate microorganisms using validated methods.

- Reprocessing validation demonstrates that, after repeated cleaning/sterilization cycles, the device still works correctly and remains safe.

Even if a device looks clean, a facility would need validated evidence that repeated reprocessing does not alter safety or performance. Single-use devices are generally not designed or validated to withstand repeated reprocessing while maintaining the same performance.

Single-use labeling affects what a facility is allowed to do

Healthcare facilities follow strict protocols and regulations. When a device is labeled single-use, clinics typically align policies with that labeling to remain compliant and to protect patient safety.

If a device is labeled single-use, facilities typically follow that labeling to help protect patients and remain compliant.

Not designed for reprocessing; cleaning is not validated reuse

Common Questions Patients Ask (FAQ)

“Is it ever safe to reuse a single-use device?”

A device labeled single-use is intended and validated for one-time use. Reuse can change sterility and performance in ways that are hard to fully control. ClearPath single-use-only labeling should be followed.

“Does single-use mean I’m paying more?”

The device is one part of the total procedure cost. Coverage depends on your diagnosis, your plan, and where the procedure is performed. It’s reasonable to ask:

- what costs are expected

- what portion may be covered by insurance

“What happens to the device after my procedure?”

After use, the ClearPath Nasal Balloon Catheter (CNB) device is disposed of according to medical waste disposal protocols. Your facility handles this as part of standard clinical operations. For a step-by-step patient overview of the visit itself, see what to expect during an office-based balloon septoplasty.

“How can I tell the device used was new?”

You can ask your clinic directly:

- whether the device is opened in the procedure setting

- what their single-use compliance steps are

It’s also fine to request a brief walk-through of their infection prevention process. Many clinics are used to these questions, and asking them can help you feel more confident going into the appointment.

Asking these questions can help you feel informed before your appointment.

What to Ask Your ENT Before Balloon Septoplasty

Safety and sterility questions

- “Is the ClearPath Nasal Balloon Catheter (CNB) device single-use and opened in the procedure setting?”

- “What infection prevention steps do you follow before and during the procedure?”

- “Where can I review the device Instructions for Use (IFU)?” You can also view the Instructions for Use (IFU) online.

Procedure-fit questions

- “Am I a good candidate for balloon-assisted septoplasty?”

- “Would this be standalone or combined with other nasal procedures?”

- “What should I expect for recovery and follow-up?”

Ask your ENT whether ClearPath may be an appropriate option for your situation.

A brief conversation with your ENT can clarify whether ClearPath is appropriate for you.

Key Takeaways (Quick Summary)

- ClearPath single-use-only labeling supports sterility, helps reduce cross-contamination risk, and helps maintain consistent device performance.

- In a retrospective cohort using the ClearPath Nasal Balloon Catheter (CNB) device, the authors reported measurable improvements and no major complications observed in that cohort. Individual results and risks vary. (Dillard et al., 2026)

- If you’re unsure, ask your ENT how they ensure single-use compliance and sterility protocols—and whether ClearPath is an appropriate option for you.

If you’re considering treatment, bring these questions to your local ENT and ask specifically about ClearPath balloon-assisted septoplasty—how they handle single-use device sterility and whether you’re a candidate.

References

- Dillard J, Koudouovoh C, Lee V, et al. Outcomes of force-directed balloon-assisted endoscopic septoplasty: a retrospective analysis with a new technique and device. Rhinology Online. 2026;9:18–23. doi:10.4193/RHINOL/25.018

- ClearPath Nasal. Instructions for Use (IFU). https://www.clearpathnasal.com/instructions-for-use

This article is for educational purposes only and is not medical advice. Please consult a qualified healthcare provider for diagnosis and treatment.

Share this post

Contact us

Have questions about the ClearPath Nasal Balloon System? Our team is here to help with product inquiries, demonstrations, or order support.

ClearPath™ is a prescription medical device.This information is for educational purposes only and is not medical advice.Only a qualified physician can determine whether ClearPath™ is appropriate for you.